Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estradiol for Fear Extinction in Anorexia Nervosa
NCT02792153Phase 1Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Dec 2016
- Primary completion
- Aug 2018
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of estradiol in anorexia nervosa (AN), sponsored by Johns Hopkins University. Primary endpoint: Electrodermal skin conductance activity. Planned start Dec 2016; status: withdrawn.
02
Drugs
estradiol
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT02792153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02792153.